Brokerages Set Definitive Healthcare Corp. (NASDAQ:DH) Target Price at $5.72

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have been assigned a consensus rating of “Hold” from the eleven analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.72.

Several research analysts have recently weighed in on the stock. Stephens started coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price objective for the company. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Finally, Barclays reaffirmed an “underweight” rating and issued a $4.00 price objective on shares of Definitive Healthcare in a report on Monday, January 13th.

Definitive Healthcare Trading Down 1.6 %

Shares of NASDAQ DH opened at $4.93 on Thursday. The firm’s 50 day moving average price is $4.40 and its 200-day moving average price is $4.45. Definitive Healthcare has a 52-week low of $3.19 and a 52-week high of $10.62. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The company has a market cap of $569.51 million, a PE ratio of -1.59, a P/E/G ratio of 3.54 and a beta of 1.41.

Definitive Healthcare (NASDAQ:DH) last issued its earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.08 by ($0.03). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The business had revenue of $62.70 million for the quarter, compared to analysts’ expectations of $61.66 million. During the same quarter in the prior year, the business posted $0.01 earnings per share. On average, equities research analysts expect that Definitive Healthcare will post 0.15 EPS for the current fiscal year.

Insider Activity at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares of the company’s stock, valued at $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 14.84% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DH. SG Americas Securities LLC boosted its position in shares of Definitive Healthcare by 44.6% during the 4th quarter. SG Americas Securities LLC now owns 27,189 shares of the company’s stock valued at $112,000 after acquiring an additional 8,387 shares during the last quarter. Nisa Investment Advisors LLC grew its position in shares of Definitive Healthcare by 3,652.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock worth $29,000 after buying an additional 6,794 shares in the last quarter. Hennion & Walsh Asset Management Inc. lifted its stake in Definitive Healthcare by 34.1% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company’s stock worth $209,000 after acquiring an additional 12,946 shares during the period. JPMorgan Chase & Co. increased its position in Definitive Healthcare by 431.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company’s stock valued at $993,000 after purchasing an additional 180,323 shares during the period. Finally, 272 Capital LP increased its holdings in Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock valued at $4,980,000 after buying an additional 476,766 shares during the period. 98.67% of the stock is currently owned by institutional investors.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.